Delivery Order SPE2DB22D3016-SPE2DB25FBGQ7
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $16,220.13 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) with a completion date of September 10, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded on a competitive basis. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $12,269.50 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) with a completion date of September 30, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order transaction. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $58,642.50 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed-price contract. The award, issued on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a competitively awarded, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,965.60 to AmerisourceBergen Drug Corp for Eliquis 5 mg tablets (60-count supply) on July 21, 2025, with completion targeted for July 22, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and reflects standard pharmaceutical procurement through the federal medical supply chain. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $5,747.36 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on July 22, 2025, with completion scheduled for July 23, 2025. This is a firm fixed-price delivery order issued under a non-competitive, non-set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical supply needs, particularly supporting...
- The Defense Logistics Agency awarded a delivery order valued at $95,172.85 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on August 26, 2025, with completion targeted for August 27, 2025. This competitive award, issued under firm fixed pricing terms, supports federal medical procurement needs through AmerisourceBergen's established supply chain. The contract specifies performance from the vendor's location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,923.39 to AmerisourceBergen Drug Corp for Eliquis 5 mg tablets (60-count supply) on August 20, 2025, with an ultimate completion date of August 21, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $15,724.80 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) with an ultimate completion date of September 10, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $15,801.10 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed-price contract type. The award was made on August 5, 2025, with an ultimate completion date of August 6, 2025, and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania serves as the place of performance for this...
- The Defense Logistics Agency awarded a delivery order valued at $19,111.33 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units). This contract, executed on July 29, 2025, with an ultimate completion date of July 30, 2025, utilizes firm fixed-price pricing and was competitively awarded without any set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBGQ7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,965.60 to AmerisourceBergen Drug Corp for Eliquis 5 mg tablets (60-count packages) with a completion date of August 29, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide. The DLA Troop Support Medical contract vehicle supports multiple federal healthcare customers, including the Defense Health Agency and U.S. Coast Guard, demonstrating AmerisourceBergen Drug Corp's established capability to meet diverse federal medical supply requirements through competitive procurement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 8/28/25 |